Peginterferon alfa-2a (Rhein Minapharm Biogenetics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePeginterferon alfa-2a (Rhein Minapharm Biogenetics)

Drug Alias Name聚乙二醇干扰素α-2a (Rhein Minapharm Biogenetics)Hansenula-derived peginterferon alpha-2a (Rhein Minapharm Biogenetics)重组人干扰素α-2a (Rhein Minapharm Biogenetics)PEG-interferon alpha-2a (Rhein Minapharm Biogenetics)PEG-IFN alpha-2a (Rhein Minapharm Biogenetics) +[6]

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionImmunomodulatorsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists

TargetsInterferon alpha/beta receptor

Therapy Area/IndicationsHepatitis C

Global Approved IndicationsHepatitis C

Approved Indications in ChinaN/A

Original Approved Country/TerritoryEgypt

Original Approved Date2015/01/01

Country/TerritoryEgypt

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesRhein Minapharm Biogenetics

China Registration ClassN/A

Develop Information

Active CompaniesRhein Minapharm Biogenetics

Inactive CompaniesN/A

Active IndicationsHepatitis C

Inactive IndicationsN/A

Other Information

ATC CodeL03AB11